CI
CBAY

Conning Inc’s Cymabay Therapeutics CBAY Stock Holding History

Conning Inc’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-78,529
Closed -$492K – 382
2022
Q4 		$492K Buy
+78,529
New +$298K 0.02% 237
2019
Q4 		– Sell
-78,529
Closed -$402K – 513
2019
Q3 		$402K Hold
78,529
– – 0.01% 344
2019
Q2 		$562K Hold
78,529
– – 0.02% 295
2019
Q1 		$1.04M Hold
78,529
– – 0.03% 239
2018
Q4 		$618K Hold
78,529
– – 0.02% 297
2018
Q3 		$870K Buy
+78,529
New +$975K 0.03% 288

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return